Focus on biospecimens: The issue is the tissue. Observations on the "nCI-NIST fitness-for-purpose quality assessment and standards development workshop," October 2010

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 2, 2011, Pages 95-98

  Taylor, Clive R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FORMALDEHYDE; PARAFFIN;

AUTOMATION; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; ENZYME MECHANISM; IMMUNOHISTOCHEMISTRY; LABORATORY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; STAINING; STANDARD; WORKSHOP;

HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TISSUE FIXATION; UNITED STATES;

EID: 79951883428     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31820b2555     Document Type: Review

References (15)

1. NCI-NIST fitness-for-purpose quality assessment and standards development workshop. Gaithersburg, MD; 2010: in press.
2. Taylor CR. Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the Biological Stain Commission, June, 1991. Biotech Histochem. 1992;67: 110-117.
3. Taylor CR. Report of the immunohistochemistry steering committee of the biologic stain commission. A proposed format for package inserts for immunohistochemi (Pubitemid 23018196)
4. Shi SR, Taylor CR, eds. Immunohistochemistry and antigen retrieval based research and diagnosis. Wiley, Hoboken, New Jersey: Wiley; 2010.
5. Wolff AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
6. Goldstein NS, Hewitt SM, Taylor CR, et al. Members of Ad-Hoc Committee on Immunohiostochemistry Standardization. Recommendations for Improved Standardization of Immunohistochemistry. Appl Immunohistochem Mol Morphol. 2007;15:124-133.
7. Yaziji H, Taylor CR. Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP Task-Force Guideline Recommendations for HER2 Testing. Appl Immunohistochem Mol Morphol. 2007;15:239-241. (Pubitemid 47329912)
8. Yaziji H, Taylor CR, Goldstein N, et al. Members of the Standardization Ad-Hoc Consensus Committee. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morph. 2008;16: 513-520.
9. Jasani B, Reid V, Tristram C, et al. Standard reference material: cell line development and use of reference lines as standards for external quality assurance of HER 2 IHC and ISH Testing. In: Shi SR, Taylor CR, eds. Immunohistochemistry and Antigen Retrieval Based Research and Diagnosis Chapter 6. Wiley, Hoboken, New Jersey: Wiley; 2010: 101-122.
10. Ingram M, Tachy GB, Ward BR, et al. Tissue engineered tumor models. Biotech Histochem. 2010;85:213-219.
11. Bogen SA, Sompuram SR. Peptides as immunohistochemistry controls. In: Shi SR, Taylor CR, eds. Immunohistochemistry and Antigen Retrieval Based Research and Diagnosis Chapter 7. Wiley, Hoboken, New Jersey: Wiley; 2010:123-140.
12. Taylor CR. Quantifiable internal reference standards for immunohistochemistry; the measurement of quantity by weight. Appl Immunohistochem Mol Morph. 2006;14:253-259. (Pubitemid 44319049)
13. Taylor CR, Levenson RM. Quantification of immunohistochemistryFissues concerning methods, utility and semi-quantitative assessment. Histopathology. 2006;49:411-424. (Pubitemid 44401549)
14. Rimm D. Intrinsic Controls for Formalin Fixed, Paraffin Embedded Tissue. http://biospecimens.cancer.gov/meeting/brnsymposium/2010/ docs/Rimm%20BRN2010v3. pdf. 2010
15. UK NEQAS Annual Meetings. UKNEQAS for ICC and ISH: Trends in Diagnostic Immunohistochemistry. Cardiff 2009: Tissue Based Diagnostics: The Next Decade. Dublin 2010. http://www.uk neqas.org.uk